Home / Healthcare / Pharmaceuticals

Global Hematological Cancers Market Study 2016-2026, by Segment (Pharmacological Therapies , Stem Cell Transplantation , … …), by Market (Epidemiology , Pathophysiology of Leukemic Stem Cells , … …), by Company (Karyopharm Therapeutics ,

SKU ID :99ST-14596645 | Published Date: 12-Oct-2019 | No. of pages: 70
Summary

The global Hematological Cancers market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):


Pharmacological Therapies 
Stem Cell Transplantation 
Surgery and Radiation Therapy 
Anemia Treatment 
Thrombosis Treatment 
Neutopenia Treatment 
Symptomatic treatment
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Epidemiology 
Pathophysiology of Leukemic Stem Cells 
Kidney Diseases 
Genetic Diseases 
Other Diseases

Company Coverage (Sales data, Main Products & Services etc.):


Karyopharm Therapeutics 
Johnson & Johnson 
Roche Diagnostics A/S 
AbbVie
Novartis 
Kite Pharma 
Celgene Corporation 
Abbott Laboratories 
Beckman Coulter 
HemoCue AB 
C. R. Bard 
Siemens AG 
Sysmex 
Mindray Medical International Limited 
Bio-Rad Laboratories 
The Medicine Company 
Pharmacyclics 
Horiba 
DiagnoCure Inc. 
Astellas Pharma US 

Major Region

Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
  • PRICE
  • $1800
    $3600
    Buy Now

Our Clients